Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Unwashed platelets are platelet transfusion products prepared from donor blood without removal of plasma or other blood components, in contrast to washed platelets that undergo a washing process to remove plasma proteins, antibodies, and other substances. Unwashed platelets are commonly used for transfusion in a variety of clinical settings for patients with thrombocytopenia or active bleeding. The main mechanism is to supplement or replace recipient platelets, facilitating normal hemostasis by enabling platelet aggregation and clot formation at sites of vascular injury. Unwashed platelets may carry a higher risk of transfusion reactions compared to washed platelets in sensitive populations, due to retained plasma proteins and other soluble substances. They are generally transfused intravenously and are the standard form of platelet product in most transfusion protocols.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on unwashed platelets.